Literature DB >> 8799373

Development of a dual target-PCR for detection and characterization of measles virus in clinical specimens.

L Jin1, A Richards, D W Brown.   

Abstract

A polymerase chain reaction (PCR) method was developed for detecting measles virus (MV) RNA in a variety of clinical samples using primer pairs in the nucleocapsid (N) and matrix (M) genes in one reaction (dual target-PCR). The dual target-PCR detected MV RNA in tissue culture fluid containing 1 TCID50 of the MV Loss strain, and was as sensitive as a single target-PCR. Specificity was confirmed by the failure of the dual target-PCR to amplify products from the infected tissue culture containing related paramyxoviruses. Thirty-two of 35 (91.4%) samples collected from 23 patients with confirmed measles infection by the detection of measles specific IgM were found to be positive for MV RNA by PCR. Direct sequencing of the PCR amplicons revealed three different genotypes among the MV strains that were detected in 12 patients. The dual target-PCR method is suitable for the diagnosis of measles infection and, based on the sequencing of the PCR product DNA, for investigating the molecular epidemiology of MV strains.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8799373     DOI: 10.1006/mcpr.1996.0027

Source DB:  PubMed          Journal:  Mol Cell Probes        ISSN: 0890-8508            Impact factor:   2.365


  10 in total

Review 1.  Multiplex PCR: optimization and application in diagnostic virology.

Authors:  E M Elnifro; A M Ashshi; R J Cooper; P E Klapper
Journal:  Clin Microbiol Rev       Date:  2000-10       Impact factor: 26.132

2.  Performance of indirect immunoglobulin M (IgM) serology tests and IgM capture assays for laboratory diagnosis of measles.

Authors:  S Ratnam; G Tipples; C Head; M Fauvel; M Fearon; B J Ward
Journal:  J Clin Microbiol       Date:  2000-01       Impact factor: 5.948

3.  Multiplex PCR for typing and subtyping influenza and respiratory syncytial viruses.

Authors:  J Stockton; J S Ellis; M Saville; J P Clewley; M C Zambon
Journal:  J Clin Microbiol       Date:  1998-10       Impact factor: 5.948

4.  Characterization of measles virus strains causing SSPE: a study of 11 cases.

Authors:  L Jin; S Beard; R Hunjan; D W G Brown; E Miller
Journal:  J Neurovirol       Date:  2002-08       Impact factor: 2.643

5.  F-actin modulates measles virus cell-cell fusion and assembly by altering the interaction between the matrix protein and the cytoplasmic tail of hemagglutinin.

Authors:  Hiroshi Wakimoto; Masakatsu Shimodo; Yuto Satoh; Yoshinori Kitagawa; Kaoru Takeuchi; Bin Gotoh; Masae Itoh
Journal:  J Virol       Date:  2012-12-05       Impact factor: 5.103

6.  Measles vaccine strain from the skin rash of a DiGeorge patient receiving tumor necrosis factor inhibitor.

Authors:  Pui-Ying Iroh Tam; Benjamin R Hanisch; Kate Klammer; Aaron S DeVries
Journal:  Pediatr Infect Dis J       Date:  2014-01       Impact factor: 2.129

7.  Genetic variation in the HN and SH genes of mumps viruses: a comparison of strains from mumps cases with and without neurological symptoms.

Authors:  Aili Cui; David W G Brown; Wenbo Xu; Li Jin
Journal:  PLoS One       Date:  2013-04-24       Impact factor: 3.240

8.  Multiplex PCR: use of heat-stable Thermus thermophilus RecA protein to minimize non-specific PCR products.

Authors:  Yasushi Shigemori; Tsutomu Mikawa; Takehiko Shibata; Michio Oishi
Journal:  Nucleic Acids Res       Date:  2005-08-08       Impact factor: 16.971

9.  Sensitive detection of SARS coronavirus RNA by a novel asymmetric multiplex nested RT-PCR amplification coupled with oligonucleotide microarray hybridization.

Authors:  Zhi-wei Zhang; Yi-ming Zhou; Yan Zhang; Yong Guo; Sheng-ce Tao; Ze Li; Qiong Zhang; Jing Cheng
Journal:  Methods Mol Med       Date:  2005

Review 10.  Coronavirus Disease 2019 (COVID-19) Diagnostic Tools: A Focus on Detection Technologies and Limitations.

Authors:  Ahmad Qasem; Ameera M Shaw; Erij Elkamel; Saleh A Naser
Journal:  Curr Issues Mol Biol       Date:  2021-07-20       Impact factor: 2.976

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.